In an Australian study of 37 patients with SGLT2i diabetic ketosis with or without acidemia and 19 non-SGLT2i DKA in T1D [11], Umapathysivam et al. demonstrated that patients with SGLT2i DKA received a significantly lower insulin dose compared with patients with T1D DKA (44.0 [27.0–82.5] vs. 87.0 [63.0–124.0]; p = 0.01), corresponding with a delayed resolution of DKA compared with the T1D group (36 [24–72] vs. 18 [12–27] hours; p = 0.002). Here, INS is linked to type 1 diabetes mellitus.